CARAFATE SUMMARY
CARAFATE Tablets contain sucralfate and sucralfate is an (alpha)-D-glucopyranoside, ß-D-fructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex.
CARAFATE® (sucralfate) is indicated in:
-
Short-term treatment (up to 8 weeks) of active duodenal ulcer. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination.
-
Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers.
|
